XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Summary of Cash, Cash Equivalents and Marketable Securities Held to Maturity

The following table summarizes the Company's cash, cash equivalents and marketable securities held to maturity as of March 31, 2023 and December 31, 2022 (amounts in thousands):

 

 

As of March 31, 2023

 

 

 

Amortized
 Costs

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Estimated
Fair Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and money market funds

 

$

516,609

 

 

$

 

 

$

 

 

$

516,609

 

Total cash and cash equivalents

 

 

516,609

 

 

 

 

 

 

 

 

 

516,609

 

Marketable securities held to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury bills - short-term

 

 

101,409

 

 

 

58

 

 

 

 

 

 

101,467

 

Total cash, cash equivalents and marketable securities

 

$

618,018

 

 

$

58

 

 

$

 

 

$

618,076

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2022

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Estimated
Fair Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and money market funds

 

$

523,458

 

 

$

 

 

$

 

 

$

523,458

 

Total cash and cash equivalents

 

 

523,458

 

 

 

 

 

 

 

 

 

523,458

 

Marketable securities held to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury bills - short-term

 

 

100,299

 

 

 

24

 

 

 

 

 

 

100,323

 

Total cash, cash equivalents and marketable securities

 

$

623,757

 

 

$

24

 

 

$

 

 

$

623,781

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of Amortized Cost and Fair Value Held to Maturity Securities by Contractual Maturity The amortized cost and the fair value of the Company's held to maturity securities by contractual maturity at March 31, 2023 and December 31, 2022 are summarized below:

 

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

Amortized
 Costs

 

 

Estimated
Fair Value

 

 

Amortized
 Costs

 

 

Estimated
Fair Value

 

Maturity of one year or less

 

$

101,409

 

 

$

101,467

 

 

$

100,299

 

 

$

100,323

 

Total

 

$

101,409

 

 

$

101,467

 

 

$

100,299

 

 

$

100,323

 

 

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of March 31, 2023 and December 31, 2022 (amounts in thousands):

 

 

 

As of March 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Money market accounts

 

$

339,044

 

 

$

 

 

$

 

 

$

339,044

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Short-term contingent consideration(1)

 

$

 

 

$

 

 

$

27,834

 

 

$

27,834

 

Long-term contingent consideration

 

$

 

 

$

 

 

$

38,910

 

 

$

38,910

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2022

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Money market accounts

 

$

343,929

 

 

$

 

 

$

 

 

$

343,929

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Short-term contingent consideration

 

$

 

 

$

 

 

$

13,950

 

 

$

13,950

 

Long-term contingent consideration

 

$

 

 

$

 

 

$

51,559

 

 

$

51,559

 

(1)
The $27.8 million of short-term contingent consideration includes $14.5 million due and payable to the remaining securityholders of Avitide related to the First Earnout Year as defined in the Agreement and Plan of Merger and Reorganization with Avalon Merger Sub, Inc., which the Company entered into as part of the acquisition of Avitide in 2021. This amount is anticipated to be paid in the second quarter of 2023.
Schedule of Reconciliation of the Change in the Fair Value of Contingent Consideration - Earnout A reconciliation of the change in the fair value of contingent consideration - earnout is included in the following table (amounts in thousands):

Balance at December 31, 2022

 

$

65,509

 

Increase in fair value of contingent consideration earnouts

 

 

1,235

 

Balance at March 31, 2023

 

$

66,744

 

Schedule of Contingent Consideration Earnout Expect to be Required to Settle Include Significant Unobservable Inputs

The recurring Level 3 fair value measurement of our contingent consideration earnout that we expect to be required to settle our 2023 and 2024 contingent consideration obligation include the following significant unobservable inputs (amounts in thousands, except percent data):

 

Contingent Consideration Earnout

 

Fair Value as of
 March 31, 2023

 

Valuation Technique

 

Unobservable Input

 

Range

 

Weighted Average(1)

 

 

 

 

 

 

 

Probability of

 

 

 

 

Commercialization-based

 

 

 

 

Monte Carlo

 

Success

 

100%

 

100%

payments

 

$

 

18,974

 

Simulation

 

Earnout Discount Rate

 

5.9%-6.1%

 

6.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

23.6%

 

23.6%

Revenue and Volume-

 

 

 

 

Monte Carlo

 

Revenue & Volume

 

 

 

 

based payments

 

$

 

33,301

 

Simulation

 

Discount Rate

 

6.4%

 

6.4%

 

 

 

 

 

 

 

Earnout Discount Rate

 

5.9%-6.1%

 

6.0%

 

Unobservable inputs were weighted by the relative fair value of the contingent consideration liability.